Abstract:ShenMai Injection (SMI) is a traditional Chinese medicine that has been extensively applied in the treatment of coronary artery disease and tumor for many years. However, there is still lack of deep research on the behaviors of SMI in vivo. In this study, a reliable, specific, and sensitive method was developed for simultaneous determination of sixteen saponins found in SMI using liquid chromatography tandem mass spectrometry (LC-MS/MS). This method was successfully applied to investigate the pharmacokinetics, tissue distribution and excretion of sixteen active compounds after a single intravenous administration of SMI. These compounds included seven protopapaxdiol (PPD-type) ginsenosides (ginsenosides Rb1, Rb2, Rb3, Rc, Rd, S-Rg3, R-Rg3), six protopapaxtriol (PPT-type) ginsenosides (notoginsenoside R1, ginsenosides Re, Rf, Rg1, S-Rg2, R-Rg2), one oleanolic acid type ginsenoside (ginsenoside Ro) and two ophiopogonins (ophiopogonin D (MD-D) and ophiopogonin D' (MD-D')). Connection of the C-20 hydroxyl group to the glycoside and the chiral configuration of C-20 might significantly impact the pharmacokinetic behaviors in vivo of ginsenosides, particularly PPD-type ginsenosides. PPD-type ginsenosides were usually eliminated slowly in serum and tissues, but S/R-Rg3 bearing a free hydroxyl group at C-20 exhibited quick elimination, and R-Rg3 underwent quicker elimination than S-Rg3. The PPT-type ginsenosides, oleanolic acid type ginsenoside and ophiopogonins underwent a fast elimination from serum and tissues. There were 10 ginsenosides that could penetrate the blood-brain barrier. In contrast to other saponins, the distributions of S-Rg2, R-Rg2, S-Rg3, R-Rg3, MD-D and MD-D' in liver were higher than in kidney. Several PPD-type ginsenosides were found to have a long-term accumulation risk in some tissues, especially Rd in kidney. In the excretion study, Rg1, S-Rg2 and MD-D were mainly excreted in a prototype and other saponins were mainly excreted in the form of metabolites. Prototypes of S-Rg2, R-Rg2, S-Rg3, R-Rg3, MD-D and MD-D' exhibited higher distribution in the liver than kidney, were excreted mainly in the feces, whereas prototypes of the remaining saponins were primarily excreted via urine. To best our knowledge, this is the first study to quantitatively evaluate the tissue distribution and excretion of SMI in rats. Our research provides novel insight into the behaviors in vivo of PPD-type ginsenosides and delivers valuable information for further drug development of SMI.

Species-dependent plasma metabolism of the ester compound daidzein 7,4'di-succinic acid mon-ester-O-ethoxy (DZ5).

Pharmacokinetics and Bioavailability Study of Danshensu in Rat

Pharmacokinetics, Tissue Distribution and Excretion of Saponins after Intravenous Administration of ShenMai Injection in Rats.

Analysis of Daidzein in Nanoparticles after Oral Co-Administration with Sodium Caprate to Rats by Ultra-Performance Liquid Chromatography–quadrupole-Time-of-flight Mass Spectrometry

Determination of Daidzein in Rat Plasma by LC

A Lipophilic Prodrug of Danshensu: Preparation, Characterization, and in Vitro and in Vivo Evaluation

Metabolite identification of tanshinol borneol ester in rats by high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry

Distribution and metabolism of daidzein and its benzene sulfonates in vivo (in mice) based on MALDI-TOF MSI

Determination of Daidzein in Rat Plasma by Time-Resolved Fluoimmunoassay

Metabolic Studies of Four Soy Isoflavones in Rats by Hplc-Hr-Ms

Metabolism of Tanshinol Borneol Ester in Rat and Human Liver Microsomes

Characterization of metabolic profile of Dazhu Hongjingtian and evaluation of its anti-hypoxic constituents

Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein

[Mechanism of Mono-Hydroxylation of Daidzein in Human Liver Microsomes].

Characterization of the pharmacokinetics of dioscin in rat.

Rapid Determination and Pharmacokinetics Study of Lignans in Rat Plasma after Oral Administration of Schisandra Chinensis Extract and Pure Deoxyschisandrin

Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet

Metabolic analysis of four phenolic acids in rat by liquid chromatography-tandem mass spectrometry.

The Dose-Dependent Effect of Daidzein on Osteoporosis in the Ovariectomized Rats

Metabolic Profile of Zearalenone in Liver Microsomes from Different Species and Its in Vivo Metabolism in Rats and Chickens Using Ultra High-Pressure Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry

Metabolic profiling and pharmacokinetic studies of alkamides, a pair of cis-trans isomers N-isobutyl-2E,4E,8Z,10E/Z-dodecatetraenamide, from Asari Radix et Rhizoma by UHPLC-Q/TOF-MS and UHPLC-MS/MS